Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States

Journal of Viral Hepatitis

Volumn 12, Issue 2, 2005, Pages 192-198

  Wai, C T ^a   Fontana, R J ^a   Polson, J ^b   Hussain, M ^a   Shakil, A O ^c   Han, S H ^d   Davern, T J ^e   Lee, W M ^b   Lok, Anna S F ^a,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chronic hepatitis B; Core promoter variants; HBV genotype; Liver transplantation; Precore variants

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; LABORATORY TEST; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RACE; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VIRUS CORE;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UNITED STATES;

EID: 14844311193     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00581.x     Document Type: Article

References (25)

1. Lee WM. Acute liver failure. N Engl J Med 1993; 329: 1862-1872.
2. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
3. Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.
4. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-169.
5. Hou J, Lin Y, Waters J et al. Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis. J Gen Virol 2002; 83: 2291-2298.
6. Bernuau J, Goudeau A, Poynard T et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-651.
7. Schiodt FV, Davern TJ, Obaid Shakil A, McGuire B, Samuel G, Lee WM. Viral hepatitis-related acute liver failure. Am J Gastroenterol 2003; 98: 448-453.
8. Devarbhavi HC, Cohen AJ, Patel R, Wiesner RH, Dickson RC, Ishitani MB. Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype. Liver Transpl 2002; 8: 550-555.
9. Steinmuller T, Seehofer D, Rayes N et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002; 35: 1528-1535.
10. Chu CJ, Lok ASF. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35: 1274-1276.
11. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-1704.
12. Kosaka Y, Takase K, Kojima M et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087-1094.
13. Sato S, Suzuki K, Akahane Y et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241-248.
14. Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173-1178.
15. Laskus T, Rakela J, Nowicki MJ, Persing DH. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995; 109: 1618-1623.
16. Feray C, Gigou M, Samuel D, Bernuau J, Bismuth H, Brechot C. Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol 1993; 18: 119-122.
17. Owiredu WK, Kramvis A, Kew MC. Molecular analysis of hepatitis B virus genomes isolated from Black African patients with fulminant hepatitis B. J Med Virol 2001; 65: 485-492.
18. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-275.
19. Teo EK, Ostapowicz G, Hussain M et al. Hepatitis B infection in patients with acute liver failure in the United States. Hepatoloay 2001; 33: 972-976.
20. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120: 1009-1022.
21. Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002; 36: 1425-1430.
22. Chu CJ, Keeffe EB, Han SH et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125: 444-451.
23. Chu CJ, Keeffe EB, Han SH et al. Prevalence of HBV precore/ core promoter variants in the United States. Hepatology 2003; 38: 619-628.
24. Mayerat C, Mantegani A, Frei C. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999; 6: 299-304.
25. Imamura T, Yokosuka O, Tanaka M et al. Distribution of hepatitis B viral genotypes in acute form of liver diseases (abstract). Hepatology 2002; 36: 369A.